(Q79761771)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Huang Y

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Border WA

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Noble NA

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

21 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

515-522

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788698%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000353

25 December 2019

exact match

0 references

cites work

The progression of renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Plasmin degradation of cartilage proteoglycan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Tissue cooperation in a proteolytic cascade activating human interstitial collagenase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Plasminogen activator inhibitor-1 and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Molecular evolution of plasminogen activator inhibitor-1 functional stability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate of serpin reactive center loop insertion into beta-sheet A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

The cell biology of the plasminogen system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

TGF-beta isoforms in renal fibrogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021

Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000353

7 January 2021